share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股sec公告 ·  06/03 14:01
Moomoo AI 已提取核心信息
Charles F. Wagner Jr., an officer at Vertex Pharmaceuticals Inc., is set to sell 3,250 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,495,000. The shares to be sold were acquired through restricted stock vesting as part of compensation on various dates in February 2023, with a total of 3,250 shares vested. Wagner's transaction follows a consistent pattern of selling vested shares, as reflected in the past three months' sales data, where the same number of shares were sold for gross proceeds of $1,478,067.50. The planned sale is in accordance with a pre-arranged trading plan adopted on 02/26/2024.
Charles F. Wagner Jr., an officer at Vertex Pharmaceuticals Inc., is set to sell 3,250 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,495,000. The shares to be sold were acquired through restricted stock vesting as part of compensation on various dates in February 2023, with a total of 3,250 shares vested. Wagner's transaction follows a consistent pattern of selling vested shares, as reflected in the past three months' sales data, where the same number of shares were sold for gross proceeds of $1,478,067.50. The planned sale is in accordance with a pre-arranged trading plan adopted on 02/26/2024.
Vertex Pharmaceuticals公司的高管Charles F. Wagner Jr. 计划于2024年6月3日出售3250股普通股,市值约为$1,495,000。该股是作为2023年2月各个日期的限制性股票归属所得的一部分交易的。Wagner的交易跟他过去三个月卖出同样数量的股票套现的行为一脉相承,到目前为止,他的交易所得总共达到了$1,478,067.50。这次的计划出售是根据2024年2月26日采用的预先安排的交易计划中的规定。
Vertex Pharmaceuticals公司的高管Charles F. Wagner Jr. 计划于2024年6月3日出售3250股普通股,市值约为$1,495,000。该股是作为2023年2月各个日期的限制性股票归属所得的一部分交易的。Wagner的交易跟他过去三个月卖出同样数量的股票套现的行为一脉相承,到目前为止,他的交易所得总共达到了$1,478,067.50。这次的计划出售是根据2024年2月26日采用的预先安排的交易计划中的规定。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息